Dr Alimorad Farshchian announced earlier that he has organized a new subsidiary, Genorthix, for the purpose of developing novel therapeutics based on cell therapy for the treatment of injuries and disorders affecting the musculoskeletal system. Farshchian will transfer certain patents and license certain technology to Genorthix for use in the field of orthopedic therapies.